Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by bigbanktheoryon Apr 21, 2021 6:03pm

87 Views

Post# 33041758

I have never shorted a stock, ever.

But in my next lifetime, I would short all of them and become rich. Lol. The shorts have been putting pressure since January. Check ceo.ca. In hindsight, vxl is not the only stock on this planet being shorted now is it? I follow this stock everyday. I'm still a little confused about an entry point tbh. Glta. Jmo. DD. Can vxl be successful, I certainly hope so, because we all need all of the help we can get. BBT out :)

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China